Ladenburg Thalmann Financial Services Inc. raised its stake in Colgate-Palmolive (NYSE:CL) by 1.4% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 329,914 shares of the company’s stock after buying an additional 4,527 shares during the period. Ladenburg Thalmann Financial Services Inc.’s holdings in Colgate-Palmolive were worth $24,890,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of CL. Jacobi Capital Management LLC grew its holdings in Colgate-Palmolive by 125.5% in the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after buying an additional 803 shares in the last quarter. Virtue Capital Management LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter worth $104,000. Krilogy Financial LLC grew its holdings in shares of Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares during the period. Captrust Financial Advisors purchased a new position in shares of Colgate-Palmolive during the 2nd quarter worth $122,000. Finally, Bruderman Asset Management LLC purchased a new position in shares of Colgate-Palmolive during the 2nd quarter worth $126,000. Institutional investors own 73.87% of the company’s stock.

How to Become a New Pot Stock Millionaire

In related news, SVP John J. Huston sold 14,000 shares of the firm’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $69.44, for a total transaction of $972,160.00. Following the completion of the transaction, the senior vice president now directly owns 100,508 shares in the company, valued at approximately $6,979,275.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jennifer Daniels sold 902 shares of the firm’s stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total value of $68,389.64. Following the transaction, the insider now owns 37,788 shares of the company’s stock, valued at $2,865,086.16. The disclosure for this sale can be found here. Insiders have sold a total of 455,707 shares of company stock valued at $32,443,427 over the last 90 days. 1.02% of the stock is currently owned by company insiders.

CL has been the subject of a number of research analyst reports. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Saturday, November 25th. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a report on Tuesday, January 16th. Macquarie upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target for the company in a report on Tuesday, December 19th. Deutsche Bank initiated coverage on Colgate-Palmolive in a report on Wednesday, December 13th. They set a “hold” rating and a $75.00 price target for the company. Finally, Societe Generale cut Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price target for the company. in a report on Wednesday, November 29th. They noted that the move was a valuation call. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and five have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $77.91.

Colgate-Palmolive (CL) opened at $70.87 on Wednesday. Colgate-Palmolive has a twelve month low of $68.19 and a twelve month high of $77.91. The company has a market capitalization of $62,218.23, a PE ratio of 31.08, a P/E/G ratio of 2.63 and a beta of 0.79. The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 27.02.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 26th. The company reported $0.75 EPS for the quarter, meeting analysts’ consensus estimates of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The company had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same period last year, the business posted $0.75 EPS. Colgate-Palmolive’s revenue for the quarter was up 4.6% on a year-over-year basis. equities analysts anticipate that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 15th. Investors of record on Friday, April 20th will be issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a yield of 2.37%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.40. The ex-dividend date is Thursday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is 70.18%.

COPYRIGHT VIOLATION WARNING: This news story was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.dailypolitical.com/2018/03/14/ladenburg-thalmann-financial-services-inc-has-24-89-million-holdings-in-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.